Everolimus for Children With Recurrent or Progressive Ependymoma

NCT02155920 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Recurrent Childhood Ependymoma

Interventions

DRUG: Everolimus

Sponsor

University of Texas Southwestern Medical Center